PUBLISHER: Grand View Research | PRODUCT CODE: 1610037
PUBLISHER: Grand View Research | PRODUCT CODE: 1610037
The global continuous positive airway pressure devices market size is anticipated to reach USD 2.62 billion by 2030, growing at a CAGR of 5.45% during the forecast period, according to a new report by Grand View Research, Inc. The growing incidence of Obstructive Sleep Apnea (OSA), rising supportive initiatives by private organizations and the government for Continuous Positive Airway Pressure (CPAP) devices, technological advancements, and growing adoption of CPAP devices in home care settings due to increase in prevalence for home-based healthcare solutions and remote monitoring capabilities is fueling the market growth.
Rapid advancements have been made in integrating CPAP devices with intelligent technology and the Internet of Things (IoT). Modern CPAP devices can now connect to smartphones, tablets, and cloud-based platforms, enabling real-time monitoring and data sharing between patients and healthcare providers. This connectivity allows for remote tracking of therapy progress, instant feedback on usage, and even remote adjustments to device settings by doctors, reducing the need for in-person visits and ensuring that treatment remains effective over time. Mobile apps and innovative features also provide reminders, tips, and troubleshooting guidance, improving compliance and user engagement.
The rising preference for home-based healthcare solutions and remote monitoring capabilities boosts market growth. As healthcare systems shift care delivery from hospitals to patients' homes, there is a growing interest in leveraging sleep apnea devices for home-based noninvasive ventilation therapy. CPAP devices offer a cost-effective and convenient alternative to traditional hospital-based care, allowing patients to receive respiratory support in their homes. Home care settings allow patients to use CPAP devices in a familiar environment, enhancing comfort and therapy adherence. This is particularly significant for individuals requiring long-term management of sleep apnea, as they can integrate the device into their daily routines without the stress of hospital visits.